NHS England Bans Puberty Blockers for Under-18s
NHS England announced that puberty-suppressing hormones would no longer be routinely prescribed to children and young people with gender dysphoria outside of clinical research settings. The decision followed recommendations from the interim Cass Review and was subsequently reinforced by emergency legislation in May 2024 extending the ban to private prescriptions.
Impact & Significance
Represented the most significant restriction on trans youth healthcare in UK history, drawing both support from those advocating caution and fierce criticism from trans rights organisations who argued it denied essential care.
Reference Record
- Date
- 12 March 2024
- Era
- 2020-present
- Sources
- 2
This timeline entry is being migrated into the reference platform. Source metadata and editorial review status will be strengthened as each topic is upgraded.